{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-037789","form_type":"8-K","ticker":"CLB","cik":"0001958086","company_name":"Core Laboratories Inc. /DE/","filed_at":"2026-02-04T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.877092+00:00","generated_at":"2026-05-16T05:04:29.445225+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Core Lab Q4 rev $138.3M (+7% YoY); ex-items EPS $0.21 (-4%); declares $0.01 dividend","bullets":["Q4 revenue $138.3M (+7% YoY); GAAP EPS $0.15, ex-items $0.21 (-4% YoY).","Q4 op. income ex-items $15.7M (11% margin, -80bps YoY); free cash flow $5.1M.","FY 2025 revenue $526.5M (flat); GAAP EPS $0.68 (+3%), ex-items $0.75 (-14%).","Net debt reduced $18.7M in 2025 (17%); leverage ratio improved to 1.09x.","Declared Q1 2026 dividend $0.01/sh, payable Mar 9, record Feb 16; repurchased 1.2M shares."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-037789","json":"https://secwatch.observer/filing/0001193125-26-037789.json","markdown":"https://secwatch.observer/filing/0001193125-26-037789.md","text":"https://secwatch.observer/filing/0001193125-26-037789.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1958086/000119312526037789/0001193125-26-037789-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1958086/000119312526037789/clb-20260204.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T05:04:29.445225+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}